TXMD TherapeuticsMD, Inc. logo

TXMD TherapeuticsMD, Inc.

Healthcare
$2.12+0.47%ClosedMarket Cap: $24.5M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.91

P/S

7.32

EV/EBITDA

-5.64

DCF Value

$-17.86

FCF Yield

10.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

90.3%

Operating Margin

-111.7%

Net Margin

5.3%

ROE

0.7%

ROA

0.5%

ROIC

-8.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$724.0K$95.0K$
Q4 null$893.0K$-619.0K$
FY null$3.0M$-569.0K$
Q3 null$784.0K$152.0K$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

3 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Thompson Tommy Gdirector
BuyMon Dec 29
Walker Marlan Dofficer: Chief Executive Officer
SellWed Nov 05
Thompson Tommy Gdirector
SellWed Nov 05
Naughton Gail Kdirector
SellWed Nov 05
Collins Cooper C.director
SellWed Nov 05

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

Beta

0.58

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Peers